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analysis for creatinine and the TIINE peptide and stored at −70ºC until
analysis.
Results: Method performance and validation characteristics were estab-
lished for the immunoafﬁnity LC-MS/MS assay aimed at measuring the
45-mer with 5HyP in human urine. Validation experiments were designed
to address speciﬁc challenges related to quantiﬁcation of endogenous
analytes. The validated method has been shown to be sensitive (lower
limit of quantiﬁcation (LLOQ) 0.156 ng/mL), selective, accurate (<15%
RE), and precise (<15% CV) over a linear range of 0.156−7.5 ng/mL. The
recovery of the 45-mer peptide from the urine samples of 6 subjects was
ranging from 94.2%-108%, which indicated that the recovery was urine
matrix independent. Accuracy and precision of spiked dilution linearity
samples at 2, 4, 10, and 20-fold dilutions were <15% RE and <15%
CV, respectively. Sample stability and inter- and intra-subject variability
have been evaluated in the urine of normal and OA populations. The
method has been applied to analyze human urine samples from clinical
studies. Urinary TIINE 45-mer was consistently found to be elevated in
symptomatic patients with X-ray OA in the knee or hip (135±9 ng/mM
creatinine) as compared to levels in non-OA subjects (65±12 ng/mM),
indicating increase type II breakdown. Moreover, urinary TIINE 45-mer
was found to be inhibited in healthy volunteers upon administration of
MMP inhibitors in a dose- and time-dependent manner.
Conclusions: The immunoafﬁnity LC-MS/MS assay to quantify the most
abundant urinary type II collagen neoepitope peptide provides highly
accurate and precise concentration determination with minimal sample
preparation and has been successfully employed in clinical studies aimed
at validating the 45-mer TIINE peptide as a biomarker for MMP activity
and its role in osteoarthritis.
I-30 MICROARRAY GENE EXPRESSION PROFILING OF HUMAN
OSTEOARTHRITIC BONE SUGGESTS ALTERED BONE
REMODELLING, WNT AND TGF BETA/BMP SIGNALING
D.M. Findlay1,2, B. Hopwood3, A. Tyskin1, N.L. Fazzalari3,2. 1University
of Adelaide, Adelaide, AUSTRALIA, 2Hanson Institute, Adelaide,
AUSTRALIA, 3Institute of Medical and Veterinary Science, Adelaide,
AUSTRALIA
Purpose: In addition to degenerative changes in the articular cartilage,
osteoarthritis (OA) is characterised by alterations to subchondral bone.
Changes to bone in OA, which include increased bone volume fraction
and reduced bone mineralisation, have also been identiﬁed at sites distal
to the affected joint. Altered bone remodelling has been proposed to
underlie these bone changes in OA. To investigate the molecular basis
for these changes, we performed gene expression analysis in bone from
the proximal femur of OA and control individuals.
Methods: Messenger RNA prepared from cancellous bone samples, ob-
tained from the proximal femur, were used for both targeted gene analysis,
investigating genes thought to be centrally involved in bone turnover, and
gene microarray, using Compugen human 19K-oligo microarray slides.
In the latter experiments, we compared the gene expression proﬁles of
four sets of OA, CTL and OP bone samples (40 comparisons in total),
comprising 10 OA – CTL female, 10 OA – CTL male, 10 OA – OP female
and 10 OP – CTL female sample pairs.
Results: We identiﬁed clear expression differences between genes such
as osteocalcin, osteopontin and type I collagen, between control and
OA bone. In the microarray experiments, a large number of differentially
expressed genes was identiﬁed, and twenty-ﬁve of these genes were
conﬁrmed to be differentially expressed (p < 0.01) by real time PCR
analysis. A substantial number of the top-ranking differentially expressed
genes identiﬁed in OA bone are known to have roles in osteoblasts,
osteocytes and osteoclasts. Many of these genes are targets of either the
WNT or TGFb/BMP signalling pathways. Other differentially expressed
genes included WNT or TGFb/BMP identiﬁed as differentially expressed
in OA bone between females and males, consistent with our other data
showing biochemical differences between males and females with OA.
Conclusions: The limitation of this work is that samples were taken
at end stage disease. However, altered expression of sets of genes
involved in bone turnover suggests a molecular basis for the altered bone
remodelling observed throughout OA progression. These data may also
in part explain the gender disparity observed in OA.
I-31 PATTERNS OF JOINT DISTRIBUTION IN HAND
OSTEOARTHRITIS: GENETIC CONSIDERATIONS
G. Livshits. Tel Aviv University, Tel Aviv, ISRAEL
Purpose: 1. To examine the pattern of joint distribution in radiographic
hand osteoarthritis (HOA) development in apparently healthy human
population and to assess contribution of sex and age on it. 2. To test
the effect of the various joint degeneration features to Kellgren-Lawrence
(K-L) score of the different joints and in total. 3. To evaluate contribution
of the putative genetic factors to inter-individual variation of HOA. 4. To
test the association of the extracellular pyrophosphate channel genes
(speciﬁcally ENPP1) with the variation of the radiographic HOA in the
above population.
Methods: The study sample was comprised of Chuvashains (Europeans
living along Volga river in Russia): 1,200 individuals of both sexes, with
age range between 19 and 90 years. HAO development was assessed
radiographically for 15 joints of each hand according to K-L grading
system, with modiﬁcations. First, using extensive statistical analysis we
examined the rate and pattern of age related changes of each type
of joints (DIP, PIP etc) and each ﬁnger separately in both sexes. We
also assessed quantitatively the relative contribution of the speciﬁc joint
degeneration characteristics (such as osteophytes, OS; joint space nar-
rowing JSN; subchondral cysts, SC; etc) to the K-L grade for each type
of joint and in total. Next, 12 DNA polymorphisms, located within and
in vicinity of ENPP1 were tested in 126 nuclear families with 574 adult
individuals. Family-based association analysis was conducted between
these markers and total K-L score of HOA.
Results: As expected, we found very strong association of HAO with
age, with only minor differences between the sexes. However, the rate of
the K-L scores appearance varied substantially between the ﬁngers and
especially between the joints. The ﬁfth ﬁnger and DIP joints showed the
highest vs the ﬁrst ﬁnger and IP1 joint the lowest rate of degeneration
respectively. Cluster analysis for rows of joints and joint groups of both
hands revealed that symmetry is the most common pattern of interrela-
tionships between rows of joints as well as between the ﬁngers, when the
later were compared as entire units. The contribution of the different joint
degeneration characteristics to K-L score was very different: OS made the
major contribution to all types of joints and in total, ranging from 50% to
80%. SC was the second predictor, contributing between 10% to 23% to
K-L score. The rest made only minor contribution. Model-based statistical
genetic analysis of the total K-L score, adjusted for age and sex, showed
highly signiﬁcant contribution of the familial factors explaining >25% of
the trait variation. The model ﬁtting analysis also strongly supported the
hypothesis of the genetic effect on the OS score variation alone. Testing
for the association with DNA polymorphisms in ENPP1 gene consistently
showed signiﬁcant association (p< 0.05–0.001) with this gene, suggesting
its involvement in HOA development.
Conclusions: The present data show that the rate of HOA development
associated with age varied signiﬁcantly between the different types of
joints and ﬁngers, with osteophytosis as a major predictor of OA at all
joints. Our study highlights signiﬁcant genetic contribution to interindivid-
ual variability of HOA and clearly suggest ENPP1 gene as an important
genetic factor in the pathogenesis of idiopathic osteoarthritis.
I-32 PHENOTYPING EROSIVE OSTEOARTHRITIS OF THE HAND
L. Punzi, R. Ramonda. Rheumatology Unit-University of Padova,
Padova, ITALY
Purpose: Erosive osteoarthritis of the hand (EOA) is characterised by
an aggressive clinical course and the presence of erosive radiographic
changes. Over time, EOA has been considered as a variant of OA, a
subset of OA, a severe form of OA, an inﬂammatory phase of OA, and
an entity distinct from OA. Our aim is to phenotype EOA in order to
demonstrate that it is a distinctive subset of hand OA.
Methods:We examined studies analysing characteristic features of EOA,
including clinical, radiographic and laboratory aspects. The diagnosis
of EOA was usually based on ACR clinical criteria for hand OA and
radiographic aspects of articular erosions, at least two in two different IPs
and with the exclusion of MCPs. The deﬁnition of erosion is still a matter
for debate. Most frequently, lesions begin at the central portion of the
joint as a sharply marginated defect, usually preceded by joint narrowing.
Progression commonly leads to the so-called ‘gull-wing’ deformity due
to marginal sclerosis and osteophytes of the distal side of the joints,
while the proximal side is centrally eroded or collapsed and thinned.
Subchondral pseudocysts may be observed on the proximal side. Another
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characteristic erosion, found especially in PIP, is the so-called “saw tooth”
appearance.
Results: Although the diagnosis of EOA is based on radiographic ero-
sions, some clinical features may lead to a suspicion of EOA. According
to the deﬁnition of “inﬂammatory OA”, abrupt onset of pain, swelling,
redness, warmth and limited function of IP joints are common. Sometimes
the same features may be observed in non-EOA cases, but usually at the
disease onset, during the ﬁrst year. Characteristic of EOA is the throbbing
paresthesias of the ﬁngertips. EOA may lead to joint deformities, some
indistinguishable from those of non-EOA, such as lateral subluxations
and Heberden’s and Bouchard’s nodes, while others are seen almost
exclusively in EOA, such as instability and ankylosis of DIP and PIP and,
rarely, opera-glass deformity.
Concerning laboratory investigations, ultrasensitive CRP has been pro-
posed as marker of the disease activity. Some OA markers, such as the
CTX I, were found to be increased in the serum and urine in EOA in
comparison with nodal non-EOA. In another recent study, serum levels
of myeloperoxydase (MPO) and, at lesser extent, Coll2−1NO2, were
elevated in EOA in comparison with non-EOA.
Pattrick et al observed an increased frequency of the HLA-A1B8 and
MZ a1-antitrypsin phenotypes in patients with nodal OA. Among these,
patients with EOA had an increased frequency of the MZ a1-antitrypsin
phenotype (30 versus 9%). We found that HLA DRB1*011 was associ-
ated with EOA, in comparison with non-EOA and reference populations.
Stern et al reported an association between EOA and a genomic region
containing the interleukin-1b (Il-1b) 5810 single nucleotide polymorphism,
thus supporting a potential role for Il-1 in the pathogenesis of this severe
phenotype of hand OA.
In comparison with nodal OA, clinical aspects of EOA may sometimes
be indistinguishable, although EOA is characterized by more frequent
inﬂammatory episodes involving several joints simultaneously and may
persist for many years, while nodal generalized OA exhibits its ﬂares
mainly at onset of the involvement of each joint, in a ‘stuttering’ onset
polyarthropathy of DIPs and PIPs which resembles a ‘monoarthritis
multiplex’. Furthermore, instability and ankylosis of IPs are seen almost
exclusively in EOA.
Conclusions: According to the recent EULAR recommendations for the
diagnosis of hand OA, EOA may be considered “as subset of hand OA,
characterized by radiographic erosions targeting IP joints which may
progress to marked bone and cartilage attrition, instability and bony
ankylosis. Typically it has an abrupt onset; marked pain and functional
impairment; inﬂammatory symptoms and signs (stiffness, soft tissue
swelling, erythema, paraesthesiae); mildly elevated CRP; and a worse
outcome than non-EOA”.
I-33 EXPERIMENTAL MODEL SYSTEMS TO ASSESS JOINT PAIN
J.J. McDougall. University of Calgary, Calgary, AB, CANADA
Purpose: The majority of patients suffering from osteoarthritis (OA)
desire effective and safe pain relief. Despite the growing number of
OA patients worldwide and the pressing need for efﬁcacious analgesics,
surprisingly little is known about the source and mechanisms of OA pain
(for review see McDougall, 2006. Arthritis Res. Ther. 8: 220–229). One
of the puzzling aspects of OA pain is the apparent disconnect between
disease severity and patient reported pain levels. Animal models of OA
provide a unique opportunity to investigate joint pain in an objective and
empirical manner.
Methods:We have examined nociception in two animal models of OA viz.
the Dunkin Hartley guinea pig model of spontaneous OA and the sodium
monoiodoacetate rat model of chemically-induced OA. In the guinea pig
model, the effect of age and joint destruction on joint nociceptor activity
was determined by comparing micro-CT and histomorphological markers
of knee joint pathology with single unit electrophysiological recordings
from articular primary afferents. Nerve recordings were also performed on
monoiodoacetate-induced OA rats as well as pain behaviour responses
using hindlimb weight bearing and von Frey hair algesiometry. Pharma-
cological interventions were carried out in the rat model to help identify
the chemical mediators involved in OA pain production and to discover
novel pain therapeutics.
Results: Both animal models demonstrated heightened nerve activity at
rest (spontaneous ﬁring) and in response to mechanical rotation of the
knee in the normal working range (non-noxious mechanical stimuli) and
during noxious hyper-rotation. Disease severity in Dunkin Hartley guinea
pig knees became progressively worse with advancing age and correlated
with increased body mass; however, OA severity did not correlate with
any of the objective electrophysiological measures of nociceptor activity.
Peripheral administration of the neuropeptide antagonist VIP6−28 to
monoiodoacetate-treated rat knees, reduced joint afferent sensitization
(Schuelert & McDougall, 2006. Osteoarthr. Cart. 14: 1155–1162) and
inhibited pain behaviour (McDougall et al., 2006. Pain 123: 98–105). In
other experiments, local administration of a cannabinoid agonist attenu-
ated afferent ﬁring rate indicative of an anti-nociceptive effect in OA joints
(Schuelert & McDougall, 2008. Arthritis Rheum. 58: 145–153).
Conclusions: These studies show that OA leads to peripheral sensitiza-
tion of knee joint sensory nerves and this heightened neural activity is the
physiological basis of joint pain. The data also provide the ﬁrst objective
evidence that disease severity is a poor indicator of joint pain. Moreover,
we have identiﬁed VIP6−28 and locally administered cannabinoids as
potential treatments for OA pain. Future studies using these and other OA
models are required to elucidate further the neurophysiological processes
responsible for generating joint pain so that novel therapeutics may be
developed allowing OA patients to lead a pain-free life.
I-34 BEHAVIORAL METHODS FOR ASSESSING OA AND PAIN IN
MOUSE MODELS
W.C. Wetsel. Duke University Medical Center, Durham, NC, USA
Purpose: Osteoarthritis (OA) is a major musculoskeletal disorder that
manifests with functional limitation and pain. In the United States, the
incidences of OA are projected to double by 2020 primarily due to in-
creased obesity. Although clinicians have concentrated upon treating the
symptoms of OA and, in some cases, by advising changes in diet, various
behavioral abnormalities may accompany the disease. This presentation
will describe some methods for examining abnormal behaviors in mouse
models of OA.
Methods: Neuromuscular status can be evaluated through behavioral
tests of reﬂexes, posture, grip-strength, pole-climbing/walking, gait, and
sensorimotor skills. Pain sensitivities are examined by tests of mechan-
ical and thermal sensitivities. Anxiety-like behaviors are analyzed by
responses in the zero maze, light-dark box, open ﬁeld, and novelty-
suppressed feeding tests, whereas depressive-like behaviors are studied
by forced swim, tail suspension, and anhedonia.
Results: In a genetic model of OA, Col9a1 mice showed knee joint
degeneration and were deﬁcient in sensorimotor responses and displayed
heightened mechanical sensitivities. In a diet-induced model of OA,
C57BL/6 mice fed a high fat diet also had knee joint changes. These
animals presented with some deﬁciencies in sensorimotor skills and they
displayed anxiety-like behaviors in the zero maze, as well as analgesia
in the hot plate but appeared normal in the tail ﬂick test.
Conclusions: As anticipated, these mouse models of OA show alter-
ations in sensorimotor responses and pain sensitivities. However, the
animals also display additional behavioral abnormalities. Clinicians should
be aware that OA patients may present with similar comorbidities and
treatment of these behaviors should be considered part of the regimen
for OA therapy.
I-35 THE IDENTIFICATION OF SUSCEPTIBILITY GENES FOR THE
ONSET AND PROGRESSION OF OSTEOARTHRITIS
I. Meulenbelt, S. Bos, M. Kloppenburg, P. Slagboom. Leiden University
Medical Center, Leiden, NETHERLANDS
Purpose: To identify new osteoarthritis susceptibility genes for the onset
and progression of Osteoarthritis.
Methods: A genome-wide linkage scan and combined linkage asso-
ciation analysis was applied to 179 affected siblings and 4 trios with
generalized osteoarthritis (The GARP study). We tested for conﬁrmation
by association in 3 additional independent OA populations.
Results: Suggested evidence for linkage in the GARP study was ob-
served on chromosome 14q32.11 (LOD=3.03, P =1.9×10−4). Genotyp-
ing tagging SNPs covering three important candidate genes revealed
a common coding variant (rs225014; Thr92Ala) in the iodothyronine-
deiodinase enzyme type 2 (D2) gene (DIO2 [MIM 601413]) which
signiﬁcantly explained the linkage signal (P =0.006). Conﬁrmation and
replication by association in the additional osteoarthritis studies indi-
cated a common DIO2 haplotype, exclusively containing the minor al-
lele of rs225014 and common allele of rs12885300, with a combined
recessive odds ratio of 1.79, 95% conﬁdence interval [CI] 1.37−2.34
with P =2.02×10−5 in females cases with advanced/symptomatic hip
osteoarthritis. The gene product of this DIO2 converts intracellular pro-
hormone-3,3′,5,5′-tetraiodothyronine (T4) into the active thyroid hormone
